Chen Chao, Wei Ling, He Wenwen, Zhang Ye, Xiao Jia, Lu Yi, Wang Fei, Zhu Xiangjia
Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.
NHC Key Laboratory of Myopia, Fudan University, Shanghai 200031, China.
EClinicalMedicine. 2024 Jan 21;68:102424. doi: 10.1016/j.eclinm.2024.102424. eCollection 2024 Feb.
Liver disease is linked to series of extrahepatic multisystem manifestations. However, little is known about the associations between liver and eye diseases, especially cataract, the global leading cause of blindness. We aimed to investigate whether severe liver diseases, including non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), viral hepatitis, and liver fibrosis and cirrhosis, were associated with an increased risk of the cataract.
A total of 326,558 participants without cataract at baseline enrolled in the UK Biobank between 2006 and 2010 were included in this prospective study. The exposures of interest were severe liver diseases (defined as hospital admission), including NAFLD, ALD, viral hepatitis and liver fibrosis and cirrhosis. The outcome was incident cataract. Cox proportional hazards models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs). Each liver disease was first treated as a binary time-varying variable to investigate its association with cataract, and then was treated as a ternary time-varying variable to examine the recent (liver disease within 0-5 years) long-term (liver disease > 5 years) state associations with the risk of cataract.
After a median follow-up of 13.3 years (interquartile range, 12.5-14.0 years), 37,064 individuals were documented as developing cataract. Higher risk of cataract was found in those with severe NAFLD (HR, 1.47; 95% CI, 1.33-1.61), ALD (HR, 1.57; 95% CI, 1.28-1.94) and liver fibrosis and cirrhosis (HR, 1.58; 95% CI, 1.35-1.85), but not in individuals with viral hepatitis when exposure was treated as a binary time-varying variable (P = 0.13). When treating exposure as a ternary time-varying variable, an association between recently diagnosed viral hepatitis and cataract was also observed (HR, 1.55; 95% CI, 1.07-2.23). Results from the combined model suggested they were independent risk factors for incident cataract. No substantial changes were found in further sensitivity analyses.
Severe liver diseases, including NAFLD, ALD, liver fibrosis and cirrhosis and recently diagnosed viral hepatitis, were associated with cataract. The revelation of liver-eye connection suggests the importance of ophthalmic care in the management of liver disease, and the intervention precedence of patients with liver disease in the early screening and diagnosis of cataract.
National Natural Science Foundation of China, Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission, Clinical Research Plan of Shanghai Shenkang Hospital Development Center, Shanghai Municipal Key Clinical Specialty Program, the Guangdong Basic and Applied Basic Research Foundation and Shenzhen Science and Technology Program.
肝脏疾病与一系列肝外多系统表现相关。然而,关于肝脏疾病与眼部疾病之间的关联,尤其是白内障(全球首要致盲原因),人们了解甚少。我们旨在研究包括非酒精性脂肪性肝病(NAFLD)、酒精性肝病(ALD)、病毒性肝炎以及肝纤维化和肝硬化在内的严重肝脏疾病是否与白内障风险增加有关。
本前瞻性研究纳入了2006年至2010年间加入英国生物银行的326,558名基线时无白内障的参与者。感兴趣的暴露因素为严重肝脏疾病(定义为住院),包括NAFLD、ALD、病毒性肝炎以及肝纤维化和肝硬化。结局为新发白内障。采用Cox比例风险模型估计风险比(HR)和95%置信区间(CI)。每种肝脏疾病首先被视为二元时变变量以研究其与白内障的关联,然后被视为三元时变变量以检验近期(0至5年内的肝脏疾病)和长期(超过5年的肝脏疾病)状态与白内障风险的关联。
中位随访13.3年(四分位间距为12.5至14.0年)后,有37,064人被记录发生了白内障。在患有严重NAFLD(HR,1.47;95%CI,1.33 - 1.61)、ALD(HR,1.57;95%CI,1.28 - 1.94)以及肝纤维化和肝硬化(HR,1.58;95%CI,1.35 - 1.85)的人群中发现白内障风险较高,但当将暴露视为二元时变变量时,病毒性肝炎患者中未发现这种情况(P = 0.13)。当将暴露视为三元时变变量时,还观察到近期诊断的病毒性肝炎与白内障之间存在关联(HR,1.55;95%CI,1.07 - 2.23)。联合模型的结果表明它们是新发白内障的独立危险因素。进一步的敏感性分析未发现实质性变化。
包括NAFLD、ALD、肝纤维化和肝硬化以及近期诊断的病毒性肝炎在内的严重肝脏疾病与白内障有关。肝脏 - 眼睛联系的揭示表明眼科护理在肝脏疾病管理中的重要性,以及肝脏疾病患者在白内障早期筛查和诊断中的干预优先级。
中国国家自然科学基金、上海市科学技术委员会科技创新行动计划、上海市申康医院发展中心临床研究计划、上海市重点临床专科项目、广东省基础与应用基础研究基金以及深圳市科技计划。